Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
CR1L encodes a membrane-bound inhibitor of complement activation, which contains several tandemly arranged short consensus repeats (SCRs) of approximately 60 amino acids. Zusätzlich bieten wir Ihnen Complement Component (3b/4b) Receptor 1-Like Antikörper (23) und Complement Component (3b/4b) Receptor 1-Like Proteine (3) und viele weitere Produktgruppen zu diesem Protein an.
Showing 2 out of 6 products:
CR1L transcript appears to be limited to hematopoietic and fetal lymphoid tissue.
Factor H (zeige CFH ELISA Kits) and Crry are critical for regulating complement activation at distinct anatomic sites within the kidney.
this study has provided direct evidence for a role of Crry in controlling spontaneous alternative pathway complement activation on renal tubular epithelial cells.
HBx can up-regulate CD59 (zeige CD59 ELISA Kits) and Crry expression in podocytes through activating the P38 (zeige CRK ELISA Kits) pathway.
Crry costimulation enhanced the in vitro expansion of natural Treg cells while maintaining their phenotypic and suppressive properties. Crry-expanded Treg cells decreasing antigen-dependent secretion of cytokines.
Stmn2 (zeige STMN2 ELISA Kits) and the chromosome 14 Rarb (zeige RARB ELISA Kits) region, but not Cr1 (zeige TDGF1 ELISA Kits) or Clu (zeige CLU ELISA Kits) or Picalm (zeige PICALM ELISA Kits), have roles in prion (zeige PRNP ELISA Kits) disease.
There is a significant reduction in the numbers of both neutrophils and macrophages in cardiac isografts isolated from mice treated with either complement receptor 2-Crry or CR2-factor H (zeige CFH ELISA Kits).
Crry is clearly present in the placentas from spontaneous abortions in mice.
Crry is the only membrane-bound complement regulator expressed on the basolateral surface of murine renal tubular epithelial cells under in vitro culture conditions.
Data show that a single-nucleotide polymorphism in the first short consensus repeat of Sle1c Crry introduced a novel N-linked glycosylation site likely responsible for structural alteration.
mesangial cell Crry limits complement activation and subsequent neutrophil recruitment in the setting of local immune complex deposition.
This gene encodes a membrane-bound inhibitor of complement activation, which contains several tandemly arranged short consensus repeats (SCRs) of approximately 60 amino acids. The encoded protein may play a role in tumor immune surveillance, which is unrelated to complement inhibition. Three alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
complement component (3b/4b) receptor 1-like
, complement regulatory GPI-anchor protein
, 5I2 antigen
, Complement receptor related protein
, antigen 5I2
, complement component receptor 1-like protein
, complement receptor type 1
, complement regulatory protein Crry
, complement C4b-binding protein CR-1-like protein
, complement receptor related protein
, protein p65